Summary.-This is a study of The rate of cell production found in this tumour is lower than the values reported in the literature for other malignancies. The calculated mitotic duration is long, but similar to previously reported values. The cell loss factor is high: in the static tumour it is 1-0, and in the regressing tumours greater than 1.0. In regressing tumours, the rate of cell loss was 30% higher than the rate of cell production. These tumours did not differ histologically from nearly florid tumours which were increasing in size. It is postulated that regression is determined by local vascular or mechanical factors, supplemented possibly by delayed hypersensitivity responses in some patients.
cell loss factor were calculated.
The average actual clinical doubling time was slightly, but not significantly, higher for growing nodular tumours than for florid tumours. Some nodular tumours regressed, and one was static. The clinical doubling times of the growing tumours were similar to those reported In the literature for other human malignancies. Kinetic studies of static and regressing human tumours have not been reported previously.
The rate of cell production found in this tumour is lower than the values reported in the literature for other malignancies. The calculated mitotic duration is long, but similar to previously reported values. The cell loss factor is high: in the static tumour it is 1-0, and in the regressing tumours greater than 1.0. In regressing tumours, the rate of cell loss was 30% higher than the rate of cell production. These tumours did not differ histologically from nearly florid tumours which were increasing in size. It is postulated that regression is determined by local vascular or mechanical factors, supplemented possibly by delayed hypersensitivity responses in some patients.
KAPOSI'S sarcoma is primarily cutaneous, though it may involve many tissues in the body (Lothe, 1963) . It was originally described in Hungary by Kaposi (1>872) , but the disease is most prevalent in equatorial Africa and usually affects males. The natural history is variable, and is related both to the gross morphology and to the histology of the tumour (Taylor et al., 1971a) . Clinically three main forms can be recognized.
Nodules retain their covering of epidermis, are confined to the skin, grow slowly and run an indolent course. Spontaneous complete regression may be noted in some, whilst an adjacent lesion may be growing. Such tumours are usually composed of a mixture of spindle cells, vascular slits and vascular channels. Frequently there is fibrosis round the tumour or lymphocytic infiltration.
Florid (fungating) tumours grow rapidly and ulcerate. They may penetrate several tissue planes to involve underlying bone. Histologically they are usually monocellular, with a proliferation of large pale spindle cells, and the vascular component is less obvious. Mitoses are seen more frequently in these sections than in those characterized by a mixed cell pathology (Taylor et al., 1971a) . However, some of these fungating tumours are frankly anaplastic and show cellular pleomorphism and large areas of necrosis. In such tumours a histological diagnosis may be impossible unless more typical nodules are located elsewhere.
Infiltrative tumours and skin plaques have also been described but are less common.
The protracted course of nodular disease led to a search for immunological responses to the tumour cells and we have reported delayed hypersensitivity reactions to autologous tumour cells from these lesions, demonstrable both in vivo and in vitro (Taylor and Ziegler, 1974) .
However, differing growth rates of nodular and florid tumours must be an expression of variation either of the rate of cell proliferation or of the rate of cell loss. In the present study we have calculated these parameters and compared them with the gross morphology.
PATIENTS AND METHODS
Patients admitted to the Uganda Cancer Institute in 1969 and 1970 with a clinical diagnosis of Kaposi's sarcoma were potentially available for this study. All were males, with a duration of symptoms ranging from 1 month to 8 years. Those excluded required urgent treatment or withheld informed consent. None had had therapy within the previous 2 years.
On admission the patients underwent a full clinical and radiological investigation and blood count. The cutaneous tumours were classified as nodular, florid or infiltrative (Taylor et al., 1971a) , and the greatest and least diameters were measured at right angles to each other, using a vernier calliper.
Being intracutaneous, the tumours project from the skin (Figs. 1 and 2) and were easily positioned within the blades of the calliper. The tumours were seen on section to be intracutaneous spheroids, so no correction for skin thickness was made. Tumour volume was computed, using the 2 diameters measured, and the mean of these as an estimate of the third diameter, as ir/6 times the product of the 3 diameters.
The patients were then reviewed as out-patients or in the ward until the time of the second measurement. This was followed by a biopsy from one edge of the lesion (Biopsy 1). In 4 patients, biopsies were taken both from a florid tumour and from an adjacent nodule. The patients were than given 10 mg Colcemid (Ciba) was removed by biopsy excision (Biopsy 2). All these procedures were approved by the Makerere Ethical Committee. The biopsy specimens were fixed in formalin and embedded in wax. Thin (4-jum) sections were stained with haematoxylin and celestine blue. Tumour cell nuclei were counted using a x 1000 oil immersion lens, and a graticule square. Consecutive areas were examined using the microscope vernier, but necrotic areas were excluded from the count. The cells adjacent to vascular slits were counted, but capsular fibrocytes and endothelial cells lining formed blood vessels were not included. The metaphases in 5 x 1000 spindle cells were recorded for each biopsy.
The mitotic count (M) is given as the number of mitoses in Biopsy 1 per 1000 cells. The rate of cell production (R) is the slope of the regression line from Biopsy 1 to the observed mitotic count in Biopsy 2 with Colcemid. This method was considered to be the best way to find the rate of cell production and to calculate the mitotic duration (Elgjo, 1966 T-R For a description of this method, see Refsum and Berdal (1967) , and Bjerknes (1974) .
The discrepancy between the actual doubling time (TD) and the potential doubling time (T.), is the rate of cell loss, which may be calculated from the formula L = R-r From the rate of cell loss we may calculate a cell loss factor, expressing the rate of cell loss as a fraction of the rate of cell production: A = L/R Values of A > 10 imply that cells are lost faster than they are created in the tumour, and the tumour is thus shrinking.
The mitotic duration (D) has been calculated by dividing the mitotic count (M) without Colcemid by the mitotic rate (R)
General
It is difficult to obtain accurate knowledge of human tumour cell kinetics because of the nature of the observations. The material is small, almost all methods are time consuming and, for ethical and practical reasons, only a few methods can be applied to man. The biological variation is also very wide.
We have chosen to present the results as actual values measured and calculated, and in many cases we have calculated the mean value for nodules and florid tumours which must be looked upon in the light of the above reservations. For a general discussion of the kinetic characterization of malignant tumours, see Iversen (1976) .
The patients and their tumours
Nine patients were examined (Table   I (Vogel et al., 1971) . Four patients (Nos. 1, 3, 4 and 5) had both nodular and (Table  IV) . With the exception of these 4 patients, however, nodular tumours had a mixed cell histological pattern and the florid tumours were monocellular, with sheaves of spindle cells predominating. Delayed hypersensitivity responses were estimated to a variety of synthetic antigens, and to autologous tumour extract, in all but Patients 9, 2 and 6. Florid lesions were used as a source of tumour cells in those patients with that form of the disease. The results showed negative responses to tumour extract in all patients, and generally impaired responses to synthetic antigens in those with florid lesions (Taylor et al., 1971b ).
Actual growth rate There was considerable spread in the actual doubling times of growing tumours, the longest being in Patient No. 2, who had nodules alone. The growing nodules had a range of doubling times from 10-65 to 202-55 days (mean 80 i 106) whilst halving times for regressing nodules varied between 27 and 474 days (mean 193 : 245) .
The range of the actual clinical doubling times for the florid tumours was from 12-09 to 172-10 days, with a mean of 58 + 61 days. There is no statistically significant difference between the actual clinical doubling times of the growing nodular tumours (80 days) and the florid tumours (58 days), but if the whole group of nodular tumours, including the static and the decreasing tumours, are considered, our tumour measurements may be said to confirm earlier reports (Kyalwasi, 1969; Taylor et al., 1971a) , of a difference in growth rate between nodular and florid tumours, the former having the longer doubling time.
Cellular kinetics
Spindle cells formed the greater part of all tumours, blood vessels and fibrous strands being rare, but necrotic areas were seen in florid tumours. The cells adjacent to vascular slits appeared to divide more frequently than others. The appearance after Colcemid confirmed earlier reports (Clarke, 1971) , but anaphases and telophases were not seen.
The mitotic count was very variable, with a slight tendency to lower values for the nodular than for the florid tumours. The differences (7-6 against 12-7 mitoses per 1000 cells) is not statistically significant using Student's t test (0-2 > P > 0.1). (Breur, 1966) .
Comparisons have been made between Kaposi's sarcomata and lymphomata, particularly Hodgkin's disease (Lukes and Butler, 1966) , and Burkitt's lymphoma (McKinney, 1967) . The growth rate of Kaposi's sarcoma is similar to that of Hodgkin's disease (Charbit, Malaise and Tubiana, 1971) , but much slower than Burkitt's lymphoma, which has a doubling time of 3 days (Iversen et al., 1974) .
The calculation of cell production rate is based on arrest by Colcemid of the dividing cells in metaphase. Tannock (1967) doubted that colchicine was an ideal stathmokinetic drug, but Nome (1975) showed that this objection is not valid for Colcemid when a correct interval between injection and measurement is chosen. There is evidence in the literathat stathmokinetic methods may be used favourably to study tumour kinetics over a 4-h period (Iversen, 1967; Refsum and Berdal, 1 967; Smith, Thomas and Riches, 1974) . Anaphases and telophases were not seen in the sections from tumours exposed to Colcemid, and this leads us to believe that the block was complete, and supports previous observations in Burkitt's lymphoma (Iversen et al., 1974) . The small Colcemid effect in one of the florid tumours was probably partly due to impaired vascular supply, areas of necrosis being seen in the histological sections. The significance of areas of necrosis in kinetic calculations can be assessed using methods such as that reported by Smith et al. (1974) .
The stathmokinetic method has been used to measure cell production in experimental tumours (Elgjo, 1966; Nome, 1975) . Following an initial biopsy and injection of Colcemid, further biopsies were taken at 30-min intervals. A graph of arrested metaphases (Y axis) plotted against time (X axis) revealed that the line of best fit, when projected downwards, crossed the Y axis at a point close to zero. In calculating the mitotic rate of mouse epidermis Elgjo found that there was little difference between the result using the line of best fit, and that obtained by drawing a line from the mitotic count 4 h after Colcemid to the intercept of the X and Y axes. This finding may be explained by the observation that the mitotic count without a stathmokinetic substance, which comprises all mitotic phases, is almost always higher than the initial counts after Colcemid. Thus after the injection of a stathmokinetic substance the mitotic count regularly falls during 30 min and then rises again. At 1 h the number of metaphase arrests is similar to the count without stathmokinesis, and only increases thereafter.
The mitotic rate of human tumours would ideally be measured using the slope of the line of best fit through serial observations. However, this is impossible because patients cannot be exposed to a series of biopsies at 30-min intervals. In view of the work of Elgjo (1966) and Nome (1975) , we feel that under these circumstances the most accurate method of measuring the cell production is to use the slope of a straight line from the X and Y intercept through the mean value of the mitotic index at 4 h.
Measurement of the rate of cell production gave a mean of about 4-5 cells/ 1000 cells/h, with a range of 1U5 to 7-9. This shows that the cells of Kaposi's sarcomas multiply more slowly than the cells of many other human tumours. Studies reported in the literature (for review, see Iversen, 1976) show that there is wide variation in the proliferative activity of different types of malignant tumours, of different tumours of the same histological type, and even of different areas of histologically similar fields from the same tumour. When the cell production rate is used for calculation of the potential doubling time, the results for human malignant tumours given in the literature show variations from 2 to 100 days.
Calculations of the mitotic duration gave values around 2 h, with a range of 0 54 to 3-73. The mitotic duration in normal tissues is usually around 1 h. A prolonged mitotic duration has been observed in some tumours (Iversen, 1976) , and a long mitotic duration probably contributes to the high number of mitoses seen in many tumours.
The cell loss factor in Kaposi's florid and growing nodular tumours (viz. 0.8)
is similar to values reported from other human malignancies in the literature (for a review, see Iversen, 1976) . One of the tumours was not growing, and 3 were apparently regressing. In the case of Patient No. 4 the measured difference in diameter from the first to second occasion was only 0'2 mm and may have been due to local pressure by garments or bedclothes. However, these patients with regressing tumours were under observation in a ward between measurements and, as the epidermal covering was intact at the second measurement, we believe that the results reflect real loss of tumour tissue and not the result of local trauma. These 3 tumours had cell loss factors higher than 1*0, and such results have never before been reported in kinetic studies of human malignancies. It is also likely that the regressing tumours had a growth fraction of considerably less than 1-0. The cell proliferation rate is calculated as the rate of cells entering mitosis/1000 cells among all viable cells, and is thus not dependent upon knowledge of the growth fraction in these tumours. The fact that some tumours grew, while others regressed, is not due to technical difficulties in measurement, but is an obvious clinical observation, as shown in the examples in Figs. 1 and 2 .
Regrettably, none of our patients had both a growing and a regressing nodule which we were able to measure (see Figs. 1 and 2 ). Unusually, in 3 patients with co-existent nodules and florid tumours, the 2 forms had the same histological pattern (Table IV) . In the first (Patient No. 1), the nodule was atypical and exhibited faster growth and a higher proliferation rate than the florid lesion. In 2 patients (Nos. 4 and 5) nodular regression was associated with a low proliferation rate and high cell loss
The mean mitotic rate for nodules (4-2/1000 cells/h) was lower than that for florid lesions (5.6) and the potential doubling time was correspondingly increased, being 213 h for nodules and 128 h for the florid lesions. These observations further characterize the 2 clinical groups. However, there is also a higher rate of cell loss in the florid tumours, and it may be that a high growth fraction is partly responsible for the rapid increase in size seen in some of these lesions.
It is possible that the cells of the regressing nodules carried an antigen not present in the cells of the florid lesion, and that immune responses to that antigen were responsible for the regression. This appears unlikely, as the 2 forms of tumour had similar histology. Moreover, in those patients with fungating tumours, delayed hypersensitivity responses were depressed to synthetic antigens and absent to an extract made from cells of the fungating tumour. Another explanation appears to be that some local factor was responsible for the regression. This might be physical pressure due to inelasticity of skin collagen in the more superficial tumours. Alternatively, it may be that there is in fact a smaller growth fraction of the cells in these regressing tumours, and that the other cells manufacture vasoactive substances such as those described by Bhana, Hillier and Karim (1971) which, acting locally, restrict or impair vascular perfusion. Local factors may be supplemented by cell-mediated immune mechanisms directed against tumour antigens in those patients where all the nodules show spontaneous regression.
